Home › Funds › SAMLYN CAPITAL, LLC › ERAS

SAMLYN CAPITAL, LLC position in ERAS

ERASCA INC · Health Care

SAMLYN CAPITAL, LLC reported holding 2,543,535 shares of ERAS (ERASCA INC) in its Q3 2026 13F filing — a position valued at US$37.3M, representing 0.63% of its reported portfolio and ranking #45 among its reported holdings. SAMLYN CAPITAL, LLC has disclosed ERAS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)2.54M sh
Reported value held$37.29M
Portfolio Weight0.63%
First reportedQ2 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How SAMLYN CAPITAL, LLC's ERAS position evolved

SAMLYN CAPITAL, LLC first disclosed a stake in ERAS in Q2 2026 at 2,256,986 shares (US$41.3M). Across 2 filings, SAMLYN CAPITAL, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,543,535 shares valued at US$37.3M — an increase of 286,549 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 2.26M $41.35M New
Q3 2026 2.54M $37.29M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ERAS and 13F data

ERAS (ERASCA INC) is a Health Care company. 73 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$329.1M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ERAS

All ERAS fund holders →

FAQ

How long has SAMLYN CAPITAL, LLC held ERAS?

SAMLYN CAPITAL, LLC has disclosed ERAS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is SAMLYN CAPITAL, LLC's current position in ERAS?

As of Q3 2026, SAMLYN CAPITAL, LLC holds 2.54M shares of ERAS (ERASCA INC), valued at $37.29M, representing 0.63% of its reported portfolio and ranking #45.

Has SAMLYN CAPITAL, LLC been buying or selling ERAS?

In the latest 13F filing (Q3 2026), SAMLYN CAPITAL, LLC increased its position in ERAS.

Which other funds hold ERAS?

Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.